about
CytoSorbents Corp specializes in treating life-threatening conditions in intensive care and cardiac surgery using proprietary polymer adsorption technology. Its flagship product, CytoSorb, is approved in the EU as an extracorporeal cytokine absorber,...
Read More
0.68
0.00
(0.00%)
61,765
XNAS Volume
XNAS 21 Jan, 2026 4:30 PM (EST)
Not Eligible
Expensive Valuation
Technically Neutral
Cytosorbents Corp Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..